35 /100
MEDIUM RISK
Score updated Jul 13, 2026

LAB — Standard BioTools Inc. Dilution Risk Tracker

Track LAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LAB — Get alerts when the score changes →

As of July 13, 2026, Standard BioTools Inc. (LAB) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Standard BioTools Inc. has a market capitalization of $448.92M, 390.07M shares outstanding, 155 institutional holders tracked. Key dilution vectors include approximately 25 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
37
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split 55%
• 50-day avg $0.96 below $1 exchange minimum
🔁 Convertible Conversion 15%
• Convertible debt present: 12.2% potential dilution
🔔 Track LAB — Get forecast alerts →

💹 Market Data

Market Cap$448.92M
Shares Outstanding390.07M
Float210.62M
Cash$306.65M
Debt$29.49M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)
155 institutional holders · 348.90M shares
#1 Casdin Capital, LLC 88.78M shares
#2 VIKING GLOBAL INVESTORS LP 58.65M shares
#3 MAK CAPITAL ONE LLC 26.17M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.43M
Days to Cover1.0
% of Float1.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LAB Shareholders

Standard BioTools Inc. (LAB) has a DilutionScore of 35/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for LAB shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LAB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LAB alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LAB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LAB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LAB
📊 LAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LAB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.